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Primary central nervous system lymphomas (PCNSL) frequently reveal genomic instability. We analysed different functional genetic
variants affecting the folate and homocysteine metabolism important for DNA integrity in 31 PCNSL patients and 142 controls. We
found significantly less carriers of the methionine synthase c.2756A4G (D919G) missense polymorphism among the patients (0.16
vs 0.42; odds ratio 0.26, CI95%: 0.09–0.74; P¼0.005), suggesting a protective function of the G allele. These data stimulate further
epidemiological and functional studies focusing on the role of homocysteine and folate metabolism in lymphoma tumorigenesis.
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Primary central nervous system lymphomas (PCNSL) are highly
malignant non-Hodgkin’s lymphomas (NHL). The vast majority of
them are of the diffuse large B-cell type (Montesinos-Rongen et al,
1999; DLBCL; Garter and Warnke, 2001). Genetic instability with
characteristic chromosomal imbalances is a characteristic feature
of PCNSL (Weber et al, 2000; Gonzalez-Gomez et al, 2003;
Nakamura et al, 2003). Since homocysteine and folate metabolism
is closely linked to DNA methylation, it considerably contributes
to the maintenance of DNA integrity (Figure 1; Mudd et al, 2001).
Consequently, genetic variants that functionally influence homo-
cysteine and folate metabolism are associated with different types
of cancer, for example, systemic NHL, acute leukaemia and
colorectal cancer (Ma et al, 1997; Skibola et al, 1999; Matsuo et al,
2001; Gonzalez-Fraile et al, 2002; Lincz et al, 2003). To test the
hypothesis that genetic variants of the homocysteine and folate
metabolism alter the susceptibility of developing PCNSL, we
analysed five polymorphisms affecting both the availability of 5,10-
methylenetetrahydrofolate as a cosubstrate in nucleic acid synthe-
sis and the level of S-adenosylmethionine (SAM) as a cosubstrate
in DNA methylation.
MATERIALS AND METHODS
We performed a case–control study using DNA samples of 31
German patients with PCNSL of the DLBCL-subtype (m/f: 11/20;
age: 61710 years; Pels et al, 2003). DNA samples of 142 healthy
German individuals (m/f: 62/80; age: 63714 years), matched for
the area of residence, served as controls. Genomic DNA was
prepared according to standard methods (Miller et al, 1988). Five
functional polymorphisms were analysed as previously described:
Cystathionin beta-synthase (CBS) c.833T4C (I278T) and 844ins68
(splice variant), methionine synthase (MS) c.2756A4G (D919G),
and methylenetetrahydrofolate reductase (MTHFR) c.677C4T
(A222V) and c.1298A4C (E429A). With the exception of CBS
I278T, these polymorphisms have a high prevalence within the
healthy German population with allele frequencies ranging
between 0.08 and 0.34 (Harmon et al, 1999; Linnebank et al,
2000, 2001).
Logistic regression analysis was used to examine the association
of single or combined polymorphisms with PCNSL and to exclude
confounding effects of age, gender or multiple testing. In addition,
w
2-tests were used to test differences of allele frequencies in
patients and controls. Threshold was defined with Po0.05. The
study was approved by the local ethics committee, and all
participants gave written informed consent.
RESULTS
The Hardy–Weinberg equilibrium was confirmed for all
polymorphisms. Allele frequencies of the control group did
not significantly differ from those reported in the literature
(Harmon et al, 1999; Linnebank et al, 2000, 2001; Table 1). The
MS c.2756A4G polymorphism (G-allele) was significantly less
frequent in patients than in controls. In all, 6% of controls,
but none of the patients were homozygous for the G-allele. At least
one mutant allele was detected in 16% of PCNSL patients
compared to 42% of controls (odds ratio (OR): 0.26, CI95%:
0.09 – 0.74; P¼0.005 in regression analysis; P¼0.007 in uncor-
rected w
2-analysis; P¼0.035 in w
2-analysis corrected for multiple
testing).
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in patients (26%) than in controls (14%). However, the difference
did not reach statistical significance in regression analysis (OR:
2.43, CI95%: 0.90 – 6.61; P¼0.08) or w
2-analysis (P¼0.09, un-
corrected). Further, we did not find any significant association of
the other polymorphisms (MTHFR c.677C4T or c.1298A4C, CBS
c.833T4C) or combinations with PCNSL.
DISCUSSION
In the present study, we investigated the association of functional
variants of the homocysteine and folate metabolism with PCNSL.
Previous studies found that the MS missense dimorphism
c.2756A4G (D919G) is associated with a lower risk of developing
colorectal cancer and types of systemic NHL (Ma et al, 1999; Lincz
et al, 2003). Our findings suggest a protective function of MS
c.2756A4G against PCNSL.
Methionine synthase c.2756A4G reduces MS activity (Harmon
et al, 1999) leading to a lower consumption of 5,10- methylenetetra-
hydrofolate by the homocysteine metabolism. As a consequence,
increased levels of 5,10-methylenetetrahydrofolate are available for
nucleic acid synthesis, thus reducing the risk of thymidin
deprivation and uracil misincorporation associated with chromo-
somal breakage (Blount et al, 1997; Harmon et al, 1999; Figure 1).
Moreover, reduced MS activity due to MS c.2756A4G results in
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Figure 1 Folate and homocysteine metabolism in human. In human homocysteine metabolism, methionine is activated to SAM. S-adenosylmethionine is
the ubiquitous methyl group donor, for example, for DNA methylation. Demethylation of SAM results in S-adenosylhomocysteine (SAH), which is
hydrolysed to homocysteine. Homocysteine can be trans-sulphurated to cystathionine by CBS or remethylated to methionine by MS. Methionine synthase
needs 5-methyltetrahydrofolate (5-CH3-FH4) as cofactor, which is generated from 5,10-methylenetetrahydrofolate (5,10-CH2FH4) by MTHFR.
Competitively, 5,10-CH2FH4 is used for nucleic acid synthesis (dTMP and purines).
Table 1 Genotypes in PCNSL patients and controls: w
2-analysis
CBSc.833 TT CT CC T-alleles C-alleles v
2 (df¼1) P (v
2)
PCNSL (n¼31) 31 (1.00) 0 0 62 (1.00) 0 0.89 0.35
Controls (n¼142) 138 (0.97) 4 (0.03) 0 280 (0.99) 4 (0.01)
CBS 844ins68 del/del del/ins ins/ins del-alleles ins-alleles v
2 P
PCNSL (n¼31) 23 (0.74) 8 (0.26) 0 54 (0.87) 8 (0.13) 2.56 0.09*
Controls (n¼142) 122 (0.86) 20 (0.14) 0 264 (0.93) 20 (0.07)
MS c.2756 AA AG GG A-alleles G-alleles v
2 P
PCNSL (n¼31) 26 (0.84) 5 (0.16) 0 57 (0.92) 5 (0.08) 7.27 0.007*
Controls (n¼142) 83 (0.59) 51 (0.36) 8 (0.06) 217 (0.76) 67 (0.24)
MTHFR c.677 CC CT TT C-alleles T-alleles v
2 P
PCNSL (n¼31) 13 (0.42) 12 (0.39) 6 (0.19) 38 (0.61) 24 (0.39) 0.23 0.64
Controls (n¼142) 66 (0.47) 52 (0.37) 24 (0.17) 184 (0.65) 100 (0.35)
MTHFR c.1298 AA AC CC A-alleles C-alleles v
2 P
PCNSL (n¼31) 16 (0.52) 12 (0.39) 3 (0.10) 44 (0.71) 18 (0.29) 0.24 0.63
Controls (n¼142) 69 (0.49) 54 (0.38) 19 (0.13) 192 (0.68) 92 (0.32)
*Results from logistic regression (as given in the text): P¼0.005 for MS c.2756A4C and P¼0.08 for CBS 844ins68.
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protective against SAM-dependent DNA hypermethylation that is
an additional risk factor for cancer development (Figure 1; Matsuo
et al, 2001; Mudd et al, 2001): several studies have demonstrated an
association of DNA hypermethylation of tumour-suppressor genes
such as p53, p15 and p16 with lymphomas (Baur et al, 1999; Moller
et al, 1999; Gonzalez et al, 2000).
The functional consequences of CBS 844ins68 are thought to be
opposite to that of MS c.2756A4G. 844ins68 lowers CBS activity
leading to an increase of homocysteine remethylation and reduced
availability of 5,10-methylentetrahydrofolate for nucleic acid synthe-
sis, while synthesis of SAM that serves as the substrate for DNA
methylation is increased (Mudd et at, 2001; Figure 1). We found a
higher frequency of CBS844ins68 in PCNSL patients than in controls.
However, this difference did not reach statistical significance.
The MTHFR variants c.677C4T and c.1298A4C and their
combinations have previously been reported to be associated with
several types of human cancer (Ma et al, 1997; Skibola et al, 1999;
Matsuo et al, 2001), but there were no significant associations of
these polymorphisms with PCNSL in our study.
In summary, the results of this study suggest a protective
function of MS c.2756A4G (G allele) against PCNSL and
encourage future studies investigating the influence of genetic
and dietary conditions of homocysteine and folate metabolism on
cancerogenesis.
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